Periodontal disease is a mixed infection, primarily involving colonization of the gingival sulcus and/or the periodontal pocket by the organism Porphyromonas gingivalis (P. gingivalis). This bacterium produces significant quantities of cysteine-class proteinases, and these are believed to be responsible for both the direct and indirect degradation of the connective tissue structure within the periodontal pocket. Two of the major proteinases released by P. gingivalis, one with Arg-X and the other with Lys-X specificity, have been purified and are suggested to be responsible for the dysregulation of the complement, kallikrein, and coagulation cascades, and as a result the increased crevicular flow, bleeding on probing, and neutrophil accumulation which are hallmarks of periodontitis. Analysis of their primary structure indicates that each proteinase is synthesized as a large polyprotein precursor which is processed into a non-covalently linked complex containing a catalytic domain and a putative adhesion/hemagglutination domain.
The Specific Aims of this proposal are designed 1) to further elucidate the role of these enzymes in disrupting both the regulation of fibrinolysis and the control of host proteinases, 2) to characterize the adhesion/hemagglutinin domains of each proteinase, 3) to investigate the mechanism(s) of maturation of each proteinase from its high molecular weight poly-protein precursor form, 4) to determine the role of each proteinase in the adhesion and invasion of host epithelial cells by P. gingivalis, and 5) to begin a collaborative investigation to determine whether vaccines produced against each proteinase might be useful therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
2R01DE009761-06A1
Application #
2015078
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1991-08-01
Project End
2001-12-31
Budget Start
1997-01-01
Budget End
1997-12-31
Support Year
6
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Georgia
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
City
Athens
State
GA
Country
United States
Zip Code
30602
Kariu, T; Nakao, R; Ikeda, T et al. (2017) Inhibition of gingipains and Porphyromonas gingivalis growth and biofilm formation by prenyl flavonoids. J Periodontal Res 52:89-96
Wilensky, A; Potempa, J; Houri-Haddad, Y et al. (2017) Vaccination with recombinant RgpA peptide protects against Porphyromonas gingivalis-induced bone loss. J Periodontal Res 52:285-291
Koneru, Lahari; Ksiazek, Miroslaw; Waligorska, Irena et al. (2016) Mirolysin, a LysargiNase from Tannerella forsythia, proteolytically inactivates the human cathelicidin, LL-37. Biol Chem :
Koro, Catalin; Hellvard, Annelie; Delaleu, Nicolas et al. (2016) Carbamylated LL-37 as a modulator of the immune response. Innate Immun 22:218-29
de Diego, IƱaki; Ksiazek, Miroslaw; Mizgalska, Danuta et al. (2016) The outer-membrane export signal of Porphyromonas gingivalis type IX secretion system (T9SS) is a conserved C-terminal ?-sandwich domain. Sci Rep 6:23123
Kalinska, Magdalena; Meyer-Hoffert, Ulf; Kantyka, Tomasz et al. (2016) Kallikreins - The melting pot of activity and function. Biochimie 122:270-82
Goulas, T; Garcia-Ferrer, I; Hutcherson, J A et al. (2016) Structure of RagB, a major immunodominant outer-membrane surface receptor antigen of Porphyromonas gingivalis. Mol Oral Microbiol 31:472-485
Benedyk, Ma?gorzata; Mydel, Piotr Mateusz; Delaleu, Nicolas et al. (2016) Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis. J Innate Immun 8:185-98
Lasica, Anna M; Goulas, Theodoros; Mizgalska, Danuta et al. (2016) Structural and functional probing of PorZ, an essential bacterial surface component of the type-IX secretion system of human oral-microbiomic Porphyromonas gingivalis. Sci Rep 6:37708
Jusko, Monika; Miedziak, Beata; Ermert, David et al. (2016) FACIN, a Double-Edged Sword of the Emerging Periodontal Pathogen Filifactor alocis: A Metabolic Enzyme Moonlighting as a Complement Inhibitor. J Immunol 197:3245-3259

Showing the most recent 10 out of 138 publications